Benign and malignant vascular tumors of the liver in adults

Seminars in Liver Disease

Volumn 28, Issue 3, 2008, Pages 302-314

  Bioulac Sage, Paulette ^a,d   Laumonier, Hervé ^b   Laurent, Christophe ^b   Blanc, Jean Frédéric ^c,d   Balabaud, Charles ^c,d  

^a HÔPITAL PELLEGRIN   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c HÔPITAL SAINT ANDRÉ   (France)

^d INSERM   (France)

Author keywords

Angiosarcoma; Epithelioid hemangioendothelioma; Hemangioma; Hepatic vascular tumors

Indexed keywords

ANABOLIC AGENT; ANGIOGENESIS INHIBITOR; BLEOMYCIN A5; DEXTRIN; DOXORUBICIN; IFOSFAMIDE; IODINATED POPPYSEED OIL; PACLITAXEL; RAPAMYCIN; THORIUM DIOXIDE;

ADULT DISEASE; ANGIOSARCOMA; ANTIANGIOGENIC ACTIVITY; ARTIFICIAL EMBOLISM; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CARCINOGENESIS; CAVERNOUS HEMANGIOMA; CHEMOEMBOLIZATION; CLINICAL EXAMINATION; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONGESTIVE HEART FAILURE; DIAGNOSTIC IMAGING; ECHOGRAPHY; HEMANGIOENDOTHELIOMA; HEMANGIOMATOSIS; HEMANGIOPERICYTOMA; HEPATIC ANGIOSARCOMA; HISTOPATHOLOGY; HUMAN; KAPOSI SARCOMA; LIVER DYSFUNCTION; LIVER GRAFT REJECTION; LIVER RESECTION; LIVER SARCOMA; LIVER TRANSPLANTATION; LIVER TUMOR; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; RADIOFREQUENCY ABLATION; RARE DISEASE; REVIEW; VASCULAR TUMOR;

ADULT; HEMANGIOENDOTHELIOMA, EPITHELIOID; HEMANGIOMA, CAVERNOUS; HEMANGIOSARCOMA; HEPATIC STELLATE CELLS; HUMANS; LIVER; LIVER NEOPLASMS; NEOPLASMS, VASCULAR TISSUE; SARCOMA, KAPOSI; TREATMENT OUTCOME;

EID: 52949093523     PISSN: 02728087     EISSN: 10988971     Source Type: Journal    
DOI: 10.1055/s-0028-1085098     Document Type: Review

References (45)

1. Zhang WJ, Ye LY, Wu LQ, et al. Morphologic, phenotypic and functional characteristics of endothelial cells derived from human hepatic cavernous hemangioma. J Vasc Res 2006;43:522-532
2. Hu D, Ran YL, Zhong X, et al. Overexpressed Derlin-1 inhibits ER expansion in the endothelial cells derived from human hepatic cavernous hemangioma. J Biochem Mol Biol 2006;39:677-685
3. Kitajima S, Liu E, Morimoto M, et al. Transgenic rabbits with increased VEGF expression develop hemangiomas in the liver: a new model for Kasabach-Merritt syndrome. Lab Invest 2005;85:1517-1527
4. Giannitrapani L, Soresi M, La Spada E, et al. Sex hormones and risk of liver tumor. Ann N Y Acad Sci 2006;1089:228-236
5. Ozakyol A, Kebapci M. Enhanced growth of hepatic hemangiomatosis in two adults after postmenopausal estrogen replacement therapy. Tohoku J Exp Med 2006;210: 257-261
6. Shimizu M, Miura J, Itoh H, Saitoh Y. Hepatic giant cavernous hemangioma with microangiopathic hemolytic anemia and consumption coagulopathy. Am J Gastroenterol 1990;85:1411-1413
7. Goodman ZD, Terraciano LM. Tumours and tumour-like lesions of the liver. In: Burt AD, Portmann BC, Ferrell LD, eds. Mac Sween's Pathology of the Liver. 5th ed. Oxford: Churchill Livingstone; 2007:761-814
8. Lehmann FS, Beglinger C, Schnabel K, Terracciano L. Progressive development of diffuse liver hemangiomatosis. J Hepatol 1999;30:951-954
9. Kim GE, Thung SN, Tsui WM, Ferrell LD. Hepatic cavernous hemangioma: under recognized associated histologic features. Liver Int 2006;26:334-338
10. Bree RL, Schwab RE, Glazer GM, Fink-Bennett D. The varied appearances of hepatic cavernous hemangiomas with sonography, computed tomography, magnetic resonance imaging and scintigraphy. Radiographics 1987;7:1153-1175
11. Vilgrain V. Tumeurs bénignes du foie. In: Vilgrain V, Menu Y, eds. Imagerie du Foie, des Voies Biliaires, du Pancréas et de la Rate. Paris: Médecine-France Flammarion; 2002:13-42
12. Dietrich CF, Mertens JC, Braden B, et al. Contrast-enhanced ultrasound of histologically proven liver hemangiomas. Hepatology 2007;45:1139-1145
13. Lee JY, Choi BI, Han JK, Kim AY, Shin SH, Moon SG. Improved sonographic imaging of hepatic hemangioma with contrast-enhanced coded harmonic angiography: comparison with MR imaging. Ultrasound Med Biol 2002;28:287-295
14. Brannigan M, Burns PN, Wilson SR. Blood flow patterns in focal liver lesions at microbubble-enhanced US. Radiographics 2004;24:921-935
15. Fergusson J, Tait N. Resection for hepatic hemangiomas. J Gastroenterol Hepatol 2007;22:1705
16. Erdogan D, Busch OR, van Delden OM, et al. Management of liver hemangiomas according to size and symptoms. J Gastroenterol Hepatol 2007;22:1953-1958
17. Lerner SM, Hiatt JR, Salamandra J, et al. Giant cavernous liver hemangiomas: effect of operative approach on outcome. Arch Surg 2004;139:818-821
18. Hinshaw JL, Laeseke PJ, Weber SM, Lee FT Jr. Multipleelectrode radiofrequency ablation of symptomatic hepatic cavernous hemangioma. AJR Am J Roentgenol 2007;189: 146-149
19. Fan RF, Chai FL, He GX, et al. Laparoscopic radio-frequency ablation of hepatic cavernous hemangioma. A preliminary experience with 27 patients. Surg Endosc 2006; 20:281-285
20. Zeng Q, Li Y, Chen Y, et al. Gigantic cavernous hemangioma of the liver treated by intra-arterial embolization with pingyangmycin-lipiodol emulsion: a multi-center study. Cardiovasc Intervent Radiol 2004;27:481-485
21. Longeville JH, de la Hall P, Dolan P, et al. Treatment of a giant haemangioma of the liver with Kasabach-Merritt syndrome by orthotopic liver transplant a case report. HPB Surg 1997;10:159-162
22. Aucejo FN, Ortiz WA, Kelly D, et al. Expanding the donor pool: safe transplantation of a cadaveric liver allograft with a 10 cm cavernous hemangioma: a case report. Liver Transpl 2006;12:687-689
23. Boyd AS, Vnencak-Jones CL, Pennington B. Microsatellite stable genome in an epithelioid hemangioendothelioma: An example of a microsatellite stable tumor. J Am Acad Dermatol 2008;58:519-521
24. Ishak KG, Sesterhenn IA, Goodman ZD, Rabin L, Stromeyer FW. Epithelioid hemangioendothelioma of the liver: a clinicopathologic and follow-up study of 32 cases. Hum Pathol 1984;15:839-852
25. Mehrabi A, Kashfi A, Fonouni H, et al. Primary malignant hepatic epithelioid hemangio-endothelioma: a comprehensive review of the literature with emphasis on the surgical therapy. Cancer 2006;107:2108-2121
26. Fujii T, Zen Y, Sato Y, et al. Podoplanin is a useful diagnostic marker for epithelioid hemangioendothelioma of the liver. Mod Pathol 2008;21:125-130
27. Lyburn ID, Torreggiani WC, Harris AC, et al. Hepatic epithelioid hemangioendothelioma: sonographic CT and MR imaging appearances. AJR Am J Roentgenol 2003;180: 1359-1364
28. Oe A, Habu D, Kawabe J, et al. A case of diffuse hepatic angiosarcoma diagnosed by FDG-PET. Ann Nucl Med 2005;19:519-521
29. Lerut JP, Orlando G, Adam R, et al. The place of liver transplantation in the treatment of hepatic epitheloid hemangioendothelioma: report of the European liver transplant registry. Ann Surg 2007;246:949-957
30. Zafrani ES. Update on vascular tumours of the liver. J Hepatol 1989;8:125-130
31. Lincoln DT, Singal PK, Al-Banaw A. Growth hormone in vascular pathology: neovascularization and expression of receptors is associated with cellular proliferation. Anticancer Res 2007;27:4201-4218
32. Tate G, Suzuki T, Mitsuya T. Mutation of the PTEN gene in a human hepatic angiosarcoma. Cancer Genet Cytogenet 2007;178:160-162
33. van Kampen RJ, Erdkamp FL, Peters FP. Thorium dioxide-related haemangiosarcoma of the liver. Neth J Med 2007; 65:279-282
34. Dogliotti E. Molecular mechanisms of carcinogenesis by vinyl chloride. Ann Ist Super Sanita 2006;42:163-169
35. Locker GY, Doroshow JH, Zwelling LA, Chabner BA. The clinical features of hepatic angiosarcoma: a report of four cases and a review of the English literature. Medicine (Baltimore) 1979;58:48-64
36. Buetow PC, Buck JL, Ros PR, Goodman ZD. Malignant vascular tumors of the liver: radiologic-pathologic correlation. Radiographics 1994;14:153-156
37. Peterson MS, Baron RL, Rankin SC. HA findings on multiphasic contrast-enhanced helical CT do not mimic hepatic hemangioma. AJR Am J Roentgenol 2000;175:165-170
38. Maeda T, Tateishi U, Hasegawa T, et al. Primary hepatic angiosarcoma on coregistered FDG PET and CT images. AJR Am J Roentgenol 2007;188:1615-1617
39. Weitz J, Klimstra DS, Cymes K, et al. Management of primary liver sarcomas. Cancer 2007;109:1391-1396
40. Maluf D, Cotterell A, Clark B, et al. Hepatic angiosarcoma and liver transplantation: case report and literature review. Transplant Proc 2005;37:2195-2199
41. Budd GT. Management of angiosarcoma. Curr Oncol Rep 2002;4:515-519
42. Ioachim HL, Adsay V, Giancotti FR, Dorset B, Melamed J. Kaposi's sarcoma of internal organs. Cancer 1995;75:1376-1385
43. Weninger W, Partanen TA, Breiteneder-Geleff S, et al. Expression of vascular endothelial growth factor and podoplanin suggests a lymphatic endothelial cell origin of Kaposi's sarcoma tumor cells. Lab Invest 1999;79:243-251
44. Stroebel P, Mayer F, Zerban H, Bannasch P. Spongiotic pericytoma: a benign neoplasm deriving from the perisinusoidal (Ito) cells in rat liver. Am J Pathol 1995;146:903-913
45. Kaiserling E, Müller H. Neoplasm of hepatic stellate cells (spongiotic pericytoma): a new tumor entity in human liver. Pathol Res Pract 2005;201:733-743